Journal article · 2026 · Open access
Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants
Archives of Pediatrics and Adolescent Medicine, 180(11), 1269 · Published 17 August 2026 · DOI 10.1001/jamapediatrics.2026.3391
In brief
“Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants” is a 2026 journal article by Ushma D. Wadia and 52 co-authors, published in Archives of Pediatrics and Adolescent Medicine. OpenAlex counts 6 citations as of 18 November 2026, which puts it in the top 2% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at PubMed Central.
- Citations
- 6
- Most cited in
- 2026 (6)
- Field-weighted impact
- 19.97
- References
- 32
- Authors
- 53
Abstract
Importance: In February 2025, Australia introduced maternal vaccination with bivalent respiratory syncytial virus prefusion F protein-based vaccine (RSVpreF) in the National Immunization Program for pregnant individuals from 28 weeks' gestation as the primary, year-round strategy to prevent RSV disease in infants 6 months of age or younger. Objective: To estimate effectiveness of RSVpreF vaccination during pregnancy against infant RSV hospitalization in Australia. Design, Setting, and Participants: This retrospective case-control study with a test-negative design was conducted in 9 hospitals across Australia with year-round respiratory testing for acute respiratory illness (ARI) among infants born from 28 weeks' gestation and hospitalized with ARI at 6 months of age or younger, March 1, 2025, through February 28, 2026. Data were analyzed March 2026 through May 2026. Exposure: Maternal RSVpreF vaccination administered from 28 weeks' gestation and 14 days or more before delivery. Main Outcomes and Measures: Maternal RSVpreF effectiveness was evaluated against hospitalization for RSV lower respiratory tract disease (RSV-LRTD, primary objective), severe RSV-LRTD, and RSV-ARI. Logistic regression with confounder adjustment was used to calculate vaccine effectiveness (VE) as (1 - adjusted odds ratio) × 100%. Results: Of 1012 infants hospitalized with ARI, 655 had LRTD, with 114 of 386 case infants (30%) and 171 of 269 control infants (64%) born to RSVpreF-vaccinated mothers (median [IQR] gestational age at vaccination, 31 weeks [29-33]). Median (IQR) maternal age at delivery was 32 years (29-35). Median (IQR) age of infants hospitalized for LRTD was 52 days (30-89); 495 of 655 (76%) were aged 3 months or younger. VE against RSV-LRTD hospitalization was 77.8% (95% CI, 66.4%-85.3%) among infants from birth through 6 months of age, 80.2% (95% CI, 71.1%-86.5%) among infants from birth through 3 months of age, 86.3% (95% CI, 79.0%-91.1%) among infants from birth through 2 months of age, and 68.2% (95% CI, 42.2%-82.5%) among infants older than 2 months through 4 months of age. Comparable VE among infants aged 6 months or younger was observed for severe RSV-LRTD (80.4%; 95% CI, 54.4%-91.6%) and RSV-ARI (80.8%; 95% CI, 70.4%-87.6%) hospitalization, with similar age-specific trends. VE was consistent across stratifications by gestational age at vaccination, vaccination to delivery time interval, and proximal administration with other vaccines during pregnancy. Descriptively, among all infants hospitalized with ARI, 161 of 499 (32%) born to RSVpreF-unvaccinated mothers had severe LRTD, while 87 of 513 (17%) born to RSVpreF-vaccinated mothers had severe LRTD. Conclusions and Relevance: Findings in this case-control study demonstrate high year-round effectiveness of RSVpreF vaccination against RSV-associated hospitalization in infants 6 months of age or younger…
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wadia, U. D., Ong, M. M., Cox, S. N., Le, H., Foo, D., Mankiewicz, S. W., Carr, J., Marshall, H. S., Clark, J. E., Britton, P. N., McMullan, B. J., Tan, Y., Wiid, Z., Tosif, S., Hung, T., Moore, H. C., Hayford, K., Cane, A. D., Fell, D. B., . . . Francis, L. (2026). Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants. Archives of Pediatrics and Adolescent Medicine, 180(11), 1269. https://doi.org/10.1001/jamapediatrics.2026.3391
MLA 9
Wadia, Ushma D., et al. “Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants.” Archives of Pediatrics and Adolescent Medicine, vol. 180, no. 11, 2026, p. 1269. https://doi.org/10.1001/jamapediatrics.2026.3391.
Chicago
Wadia, Ushma D., Madeline M. Ong, Sarah N. Cox, Huong Le, Damien Foo, Shauna Wolf Mankiewicz, Jeremy Carr, et al. 2026. “Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants.” Archives of Pediatrics and Adolescent Medicine 180 (11): 1269. https://doi.org/10.1001/jamapediatrics.2026.3391.
Harvard
Wadia, U. D. et al. (2026) ‘Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants’, Archives of Pediatrics and Adolescent Medicine, 180(11), p. 1269. doi:10.1001/jamapediatrics.2026.3391.
IEEE
U. D. Wadia et al., “Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants,” Archives of Pediatrics and Adolescent Medicine, vol. 180, no. 11, p. 1269, 2026, doi: 10.1001/jamapediatrics.2026.3391.
BibTeX
@article{wadia2026maternal,
title = {{Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants}},
author = {Wadia, Ushma D. and Ong, Madeline M. and Cox, Sarah N. and Le, Huong and Foo, Damien and Mankiewicz, Shauna Wolf and Carr, Jeremy and Marshall, Helen Siobhan and Clark, Julia Elizabeth and Britton, Philip N and McMullan, Brendan Joseph and Tan, Ye and Wiid, Zirke and Tosif, Shidan and Hung, Te‐Yu and Moore, Hannah Catherine and Hayford, Kyla and Cane, Alejandro D. and Fell, Deshayne B. and Atwell, Jessica E. and Richmond, Peter and STREETON Study Working Group and Finucane, Carolyn and Kets, Julia and Gibson, Camille and Ghosh, Louise and Kent, Jennifer and Vichnin, Michelle D. and Hunter, Guillian and Au, Catherine and others},
journal = {Archives of Pediatrics and Adolescent Medicine},
year = {2026},
volume = {180},
number = {11},
pages = {1269},
doi = {10.1001/jamapediatrics.2026.3391},
url = {https://doi.org/10.1001/jamapediatrics.2026.3391}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- RSVpreF vaccine
- maternal immunization
- respiratory syncytial virus
- vaccine effectiveness
- infant hospitalization
- lower respiratory tract disease
- acute respiratory illness
- passive immunity
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Wadia, U. D., Ong, M. M., Cox, S. N., Le, H., Foo, D., Mankiewicz, S. W., Carr, J., Marshall, H. S., Clark, J. E., Britton, P. N., McMullan, B. J., Tan, Y., Wiid, Z., Tosif, S., Hung, T., Moore, H. C., Hayford, K., Cane, A. D., Fell, D. B., . . . Francis, L. (2026). Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants. Archives of Pediatrics and Adolescent Medicine, 180(11), 1269. https://doi.org/10.1001/jamapediatrics.2026.3391
How many times has this paper been cited?
6 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the PDF from this page.
Who wrote this paper?
Ushma D. Wadia, Madeline M. Ong, Sarah N. Cox, Huong Le, Damien Foo, Shauna Wolf Mankiewicz, Jeremy Carr, Helen Siobhan Marshall, Julia Elizabeth Clark, Philip N Britton, Brendan Joseph McMullan, Ye Tan and 41 more.
What is the DOI of this paper?
10.1001/jamapediatrics.2026.3391, permanently at https://doi.org/10.1001/jamapediatrics.2026.3391. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.